Egypt

Egypt's government-owned Medical Insurance Authority is trying to reduce its massive budget deficit of US$31.2mn by increasing the price of subscriptions from EGP4 (US$0.73) to EGP8... 2010-04-23

BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underlines some of our key views for how the sector is performing in emerging markets.... 2010-04-20

We assert that Egypt's pharmaceutical sector has more potential in terms of growth and expansion prospects over the next five years than regional peers Algeria, Morocco. Our view... 2010-04-14

The Egyptian government believes that counterfeit drugs in the country could be worth around US$181mn. It also estimates that 10% of medicines found in otherwise legal pharmacies... 2010-04-09

The Egyptian pharmaceutical industry is growing steadily, with spending in this sector forecast to reach US$4.2bn by the end of 2014. With exports on the rise, we believe that the... 2010-03-11

Healthcare spending in Egypt is expected to rise from US$8.51bn in 2009 to reach US$12.7bn by 2014, at a compound annual growth rate (CAGR) of 8.3% in US dollar terms and 4.3% in... 2010-03-08

In BMI's recent analysis of the Gulf Co-operation Council (GCC) pharmaceutical market, we highlighted Saudi Arabia and the UAE as the biggest medicine spenders - reaching values of... 2010-02-05

The Egyptian Ministry of Health has announced that medicine exports in 2009 exceeded its expectations by reaching a value of EGP3.5bn (US$628mn). Comparing the ministry's forecast... 2010-01-27

BMI calculates that the value of Egypt's patented drug market will rise from US$1.60bn in 2009 to US$2.5bn by 2014, representing a compound annual growth rate (CAGR) of 9.6%. By 2019... 2010-01-20

BMI calculates that the value of Egypt's patented drug market will rise from US$1.60bn in 2009 to US$2.5bn by 2014, representing a compound annual growth rate (CAGR) of 9.6%. By 2019... 2010-01-20